Planning Your Everyday Life in Virtual Reality : a Study in Schizophrenia;

Last updated: December 12, 2022
Sponsor: Centre Hospitalier St Anne
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tourette's Syndrome

Schizotypal Personality Disorder (Spd)

Psychosis

Treatment

N/A

Clinical Study ID

NCT04011774
D17-P025
  • Ages 18-50
  • All Genders

Study Summary

Patients with schizophrenia , who visit frenquently day-care or day-care activities clinics, often experience difficulties of daily living and cognitive deficits. Living independently is a key for recovery. Cognitive remediation is a therapy which reduces deficit and improves daily living. Nowadays no program exists targeting neurocognitive functions in virtual reality which could mimic everyday life in a virtual town.

Hypotheses :

  • Persons with schizophrenia experience difficulties in daily living and disabilities to plan in everyday life. PLANI-REV program, a serious game with a navigation in a virtual town, in a 15 weekly group sessions could reduce these difficulties compared to the initial assessment. This improvement could be maintained 6 months after the end of the program.

  • PLANI-REV could also improve prospective memory, attention, working memory, and visuospatial organization.

  • PLANI-REV could induce a clinical improvement, as well as better perception of self-efficiency, self esteem, quality of life, and conversation skills.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 18 and 50 years old.
  • Diagnostic of schizophrenia or schizoaffective disorder (DSM V), attested by the MINIstructured interview (Shehan et al. 1998)
  • Who visit for months or year, weekly or several times per week, a day care, ortherapeutic activity units outpatients clinics and nursing homes
  • French Mother tongue
  • Consent of the legal representative caregiver for the patients under representativelaw (tutelle in French).
  • Clinical Stability - Therapeutic stability for at least one month.
  • National healthcare assurance

Exclusion

Exclusion Criteria:

  • Central Neurological or non stabilized somatic diseases.
  • Treatments for somatic disease with putative psychotropic effect.
  • Electroconvulsive therapy in the last six months
  • Illetrism
  • IQ< 70 established with the f-NART.
  • Substance misuse or dependence (except Nicotine) or toxic for more than 5 years.

Study Design

Total Participants: 144
Study Start date:
October 09, 2018
Estimated Completion Date:
August 09, 2024

Connect with a study center

  • Centre Hospitalier DURANT

    Etampes,
    France

    Active - Recruiting

  • Hopital les Murets

    La Queue-en-Brie, 94510
    France

    Active - Recruiting

  • Centre Hospitalier Sainte Anne

    Paris, 75674
    France

    Active - Recruiting

  • Centre Hospitalier Guillaume Régnier

    Rennes, 35703
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.